Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
Bioequivalence: Overview01:16

Bioequivalence: Overview

Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
Measurement of Bioavailability: Pharmacokinetic Methods01:30

Measurement of Bioavailability: Pharmacokinetic Methods

Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
Equivalence: In Vitro and In Vivo Bioequivalence01:17

Equivalence: In Vitro and In Vivo Bioequivalence

Bioequivalence studies are crucial in evaluating whether new drugs can match an approved one regarding pharmacological effects and clinical performance. These studies test if drugs, despite different dosage forms, share identical plasma concentration-time profiles. Three types of equivalence are central to these studies: chemical, pharmaceutical, and therapeutic. Chemical equivalence indicates that two or more drug products contain identical active ingredients in equal amounts. Pharmaceutical...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changing Referral Patterns in Paediatric Neurology: A Tertiary Outpatient Study within Brazil's Unified Health System, 2014-2024.

Neuroepidemiology·2026
Same author

Validation of the Spanish Blood Donation Knowledge Questionnaire (BDKQ-Spain) Through University-School Partnerships.

Healthcare (Basel, Switzerland)·2026
Same author

Homeopathy for Chronic Non-specific Low Back Pain: Randomised, Double-Blind, Crossover, Placebo-Controlled Clinical Trial Investigating the Efficacy of the Biotherapic Lumbar Vertebra (BIOVERT Trial).

Homeopathy : the journal of the Faculty of Homeopathy·2026
Same author

Immunological responses to tetanus, diphtheria, pertussis (Tdap) vaccine in Brazilian hematopoietic stem cell transplant recipients.

Vaccine·2026
Same author

Short-term effects of a 30-day suspension of inspiratory muscle training in patients with severe heart failure.

Heart & lung : the journal of critical care·2025
Same author

Standardized approach to small bowel bleeding in a hierarchical healthcare network with varying levels of complexity.

Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery·2025

Related Experiment Video

Updated: Jun 26, 2026

Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

Use of Bayesian methods for multivariate bioequivalence measures.

Roberto Molina de Souza1, Jorge Alberto Achcar, Edson Zangiacomi Martinez

  • 1Departamento de Medicina Social, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, S.P. Brazil.

Journal of Biopharmaceutical Statistics
|January 8, 2009
PubMed
Summary

This study presents a Bayesian approach for bioequivalence testing using multivariate pharmacokinetic data. Incorporating correlation parameters significantly enhances the accuracy and reliability of bioequivalence results.

Related Experiment Videos

Last Updated: Jun 26, 2026

Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

Area of Science:

  • Pharmacokinetics
  • Biostatistics
  • Bayesian analysis

Background:

  • Bioequivalence studies are crucial for drug approval.
  • Traditional methods often use univariate pharmacokinetic measures.
  • Assessing drug equivalence requires reliable statistical methods.

Purpose of the Study:

  • To introduce a Bayesian analysis for bioequivalence data using multivariate pharmacokinetic measures.
  • To evaluate the impact of correlation parameters on bioequivalence results.
  • To compare univariate and multivariate Bayesian approaches for bioequivalence testing.

Main Methods:

  • Bayesian analysis framework.
  • Multivariate pharmacokinetic data modeling.
  • Inclusion of correlation parameters between pharmacokinetic measures and random effects.
  • Comparison with univariate bioequivalence methods.
  • Application of Bayesian discrimination methods for model selection.

Main Results:

  • The proposed multivariate Bayesian analysis with correlation parameters significantly improves bioequivalence results.
  • Higher accuracy and reliability in bioequivalence tests were observed.
  • The study demonstrated practical advantages over traditional univariate methods.
  • Bayesian discrimination methods effectively identified optimal models for bioequivalence studies.

Conclusions:

  • Multivariate Bayesian analysis offers a more accurate and reliable approach to bioequivalence testing.
  • The incorporation of correlation parameters is key to enhancing bioequivalence assessments.
  • This methodology holds significant practical interest for regulatory agencies and pharmaceutical research.